Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis
BackgroundWhile recent studies have separately explored mutational signatures and the tumor microenvironment (TME), there is limited research on the associations of both factors in a pan-cancer context.Materials and methodsWe performed a pan-cancer analysis of over 8,000 tumor samples from The Cance...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1186357/full |
_version_ | 1797822559819923456 |
---|---|
author | Li-Zhi Luo Sheng Li Chen Wei Jiao Ma Li-Mei Qian Yan-Xing Chen Shi-Xiang Wang Qi Zhao |
author_facet | Li-Zhi Luo Sheng Li Chen Wei Jiao Ma Li-Mei Qian Yan-Xing Chen Shi-Xiang Wang Qi Zhao |
author_sort | Li-Zhi Luo |
collection | DOAJ |
description | BackgroundWhile recent studies have separately explored mutational signatures and the tumor microenvironment (TME), there is limited research on the associations of both factors in a pan-cancer context.Materials and methodsWe performed a pan-cancer analysis of over 8,000 tumor samples from The Cancer Genome Atlas (TCGA) project. Machine learning methods were employed to systematically explore the relationship between mutational signatures and TME and develop a risk score based on TME-associated mutational signatures to predict patient survival outcomes. We also constructed an interaction model to explore how mutational signatures and TME interact and influence cancer prognosis.ResultsOur analysis revealed a varied association between mutational signatures and TME, with the Clock-like signature showing the most widespread influence. Risk scores based on mutational signatures mainly induced by Clock-like and AID/APOBEC activity exhibited strong pan-cancer survival stratification ability. We also propose a novel approach to predict transcriptome decomposed infiltration levels using genome-derived mutational signatures as an alternative approach for exploring TME cell types when transcriptome data are unavailable. Our comprehensive analysis revealed that certain mutational signatures and their interaction with immune cells significantly impact clinical outcomes in particular cancer types. For instance, T cell infiltration levels only served as a prognostic biomarker in melanoma patients with high ultraviolet radiation exposure, breast cancer patients with high homologous recombination deficiency signature, and lung adenocarcinoma patients with high tobacco-associated mutational signature.ConclusionOur study comprehensively explains the complex interplay between mutational signatures and immune infiltration in cancer. The results highlight the importance of considering both mutational signatures and immune phenotypes in cancer research and their significant implications for developing personalized cancer treatments and more effective immunotherapy. |
first_indexed | 2024-03-13T10:10:53Z |
format | Article |
id | doaj.art-c77c1e6d042a44c8b4878fd7153bef55 |
institution | Directory Open Access Journal |
issn | 1664-3224 |
language | English |
last_indexed | 2024-03-13T10:10:53Z |
publishDate | 2023-05-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj.art-c77c1e6d042a44c8b4878fd7153bef552023-05-22T04:26:00ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-05-011410.3389/fimmu.2023.11863571186357Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysisLi-Zhi Luo0Sheng Li1Chen Wei2Jiao Ma3Li-Mei Qian4Yan-Xing Chen5Shi-Xiang Wang6Qi Zhao7State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, ChinaSchool of Public Health, Sun Yat-Sen University, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, ChinaBackgroundWhile recent studies have separately explored mutational signatures and the tumor microenvironment (TME), there is limited research on the associations of both factors in a pan-cancer context.Materials and methodsWe performed a pan-cancer analysis of over 8,000 tumor samples from The Cancer Genome Atlas (TCGA) project. Machine learning methods were employed to systematically explore the relationship between mutational signatures and TME and develop a risk score based on TME-associated mutational signatures to predict patient survival outcomes. We also constructed an interaction model to explore how mutational signatures and TME interact and influence cancer prognosis.ResultsOur analysis revealed a varied association between mutational signatures and TME, with the Clock-like signature showing the most widespread influence. Risk scores based on mutational signatures mainly induced by Clock-like and AID/APOBEC activity exhibited strong pan-cancer survival stratification ability. We also propose a novel approach to predict transcriptome decomposed infiltration levels using genome-derived mutational signatures as an alternative approach for exploring TME cell types when transcriptome data are unavailable. Our comprehensive analysis revealed that certain mutational signatures and their interaction with immune cells significantly impact clinical outcomes in particular cancer types. For instance, T cell infiltration levels only served as a prognostic biomarker in melanoma patients with high ultraviolet radiation exposure, breast cancer patients with high homologous recombination deficiency signature, and lung adenocarcinoma patients with high tobacco-associated mutational signature.ConclusionOur study comprehensively explains the complex interplay between mutational signatures and immune infiltration in cancer. The results highlight the importance of considering both mutational signatures and immune phenotypes in cancer research and their significant implications for developing personalized cancer treatments and more effective immunotherapy.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1186357/fullmutational signaturestumor microenvironmentcancer genomicscancer prognosisimmunotherapy |
spellingShingle | Li-Zhi Luo Sheng Li Chen Wei Jiao Ma Li-Mei Qian Yan-Xing Chen Shi-Xiang Wang Qi Zhao Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis Frontiers in Immunology mutational signatures tumor microenvironment cancer genomics cancer prognosis immunotherapy |
title | Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis |
title_full | Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis |
title_fullStr | Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis |
title_full_unstemmed | Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis |
title_short | Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis |
title_sort | unveiling the interplay between mutational signatures and tumor microenvironment a pan cancer analysis |
topic | mutational signatures tumor microenvironment cancer genomics cancer prognosis immunotherapy |
url | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1186357/full |
work_keys_str_mv | AT lizhiluo unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis AT shengli unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis AT chenwei unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis AT jiaoma unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis AT limeiqian unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis AT yanxingchen unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis AT shixiangwang unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis AT qizhao unveilingtheinterplaybetweenmutationalsignaturesandtumormicroenvironmentapancanceranalysis |